"At Kravis Children’s Hospital, we provide advanced care for allergic disorders, many of which we have developed or refined through our relationship with the Jaffe Food Allergy Institute. Treating patients helps us see the sorts of questions that require researching and informs our studies. We use what we learn from our research to guide our clinical care."

During the past decade, Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator, "Novartis Pharmaceuticals" with 1 trials as a collaborator and "Rho Federal Systems Division, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" are "Atopic Dermatitis" (1 trials), "Multi-food Allergy" (1 trials) and "Peanut Allergy" (1 trials). Many other conditions were trialed in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" in a lesser frequency.

Most popular intervention types in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Double-Blind Placebo-Controlled Food Challenge Based Treatment" (1 trials), "Dupilumab" (1 trials), "Multi-Allergen Oral Immunotherapy" (1 trials), "Omalizumab" (1 trials) and "Placebo for Multi-Allergen Oral Immunotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Icahn School of Medicine at Mount Sinai: Department of Pediatrics Allergy & Immunology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".